These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37303752)

  • 1. Effectiveness of tumor necrosis factor inhibitors in children with enthesitis-related arthritis: a single-center retrospective analysis.
    Zhang T; Huang S; Guo Y; Jin J; Yan W; Wang P; Fang Y; Liu Y; Pan Y; Fan Z; Yu H
    Front Pediatr; 2023; 11():1122233. PubMed ID: 37303752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
    Weiss PF; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan-DeWitt E; Feudtner C
    J Rheumatol; 2018 Jan; 45(1):107-114. PubMed ID: 28916542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthritis Research Consortium of Canada Scoring System for Sacroiliitis in Juvenile Spondyloarthritis/Enthesitis-related Arthritis: A Reliability, Validity, and Responsiveness Study.
    Panwar J; Tse SML; Lim L; Tolend MA; Radhakrishnan S; Salman M; Moineddin R; Doria AS; Stimec J
    J Rheumatol; 2019 Jun; 46(6):636-644. PubMed ID: 30709956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enthesitis-related arthritis: the clinical characteristics and factors related to MRI remission of sacroiliitis.
    Li J; Zhu Y; Guo G
    BMC Musculoskelet Disord; 2022 Dec; 23(1):1054. PubMed ID: 36461063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease.
    Donnithorne KJ; Cron RQ; Beukelman T
    J Rheumatol; 2011 Dec; 38(12):2675-81. PubMed ID: 22089470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study.
    Zhang K; Zheng Y; Han Q; Liu Y; Wang W; Ding J; Wang Y; Zhang B; Jia J; Zheng M; Zheng Z; Zhu P
    Front Immunol; 2021; 12():740980. PubMed ID: 34659233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.
    Kısaarslan AP; Sözeri B; Gündüz Z; Zararsız G; Poyrazoğlu H; Düşünsel R
    Eur J Rheumatol; 2019 Jul; 6(3):130-135. PubMed ID: 31070580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic.
    Lanças SHS; Furlan MZB; Fernandes TAP; Drumond SGL; Magalhães CS
    Adv Rheumatol; 2024 May; 64(1):39. PubMed ID: 38720369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial involvement in enthesitis-related arthritis: results from a single-center cohort.
    Guo Y; Fang Y; Zhang T; Pan Y; Wang P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2023 Feb; 21(1):13. PubMed ID: 36747282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
    Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
    BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.
    Otten MH; Prince FH; Twilt M; Ten Cate R; Armbrust W; Hoppenreijs EP; Koopman-Keemink Y; Wulffraat NM; Gorter SL; Dolman KM; Swart JF; van den Berg JM; van Rossum MA; van Suijlekom-Smit LW
    J Rheumatol; 2011 Oct; 38(10):2258-63. PubMed ID: 21844151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
    Malottki K; Barton P; Tsourapas A; Uthman AO; Liu Z; Routh K; Connock M; Jobanputra P; Moore D; Fry-Smith A; Chen YF
    Health Technol Assess; 2011 Mar; 15(14):1-278. PubMed ID: 21439251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the outcomes between early and late anti-tumor necrosis factor therapy in patients with enthesitis-related subcategory of juvenile idiopathic arthritis: a multi-center study in Southeast Asia.
    Vilaiyuk S; Lerkvaleekul B; Jino J; Charuvanij S; Book YX; Arkachaisri T
    Expert Opin Biol Ther; 2022 Oct; 22(10):1323-1332. PubMed ID: 35876095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.
    Gmuca S; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan EM; Weiss PF
    Arthritis Res Ther; 2017 May; 19(1):84. PubMed ID: 28464909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients.
    Lamot L; Miler M; Vukojević R; Vidović M; Lamot M; Trutin I; Gabaj NN; Harjaček M
    Front Med (Lausanne); 2021; 8():650619. PubMed ID: 33763437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
    Kilic O; Kasapcopur O; Camcioglu Y; Cokugras H; Arisoy N; Akcakaya N
    Rheumatol Int; 2012 Sep; 32(9):2675-9. PubMed ID: 21789614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging findings in juvenile spondyloarthropathy and effects of treatment observed on subsequent imaging.
    Lin C; MacKenzie JD; Courtier JL; Gu JT; Milojevic D
    Pediatr Rheumatol Online J; 2014; 12():25. PubMed ID: 25067925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong.
    Chan OM; Lai BM; Leung AS; Leung TF; Ho AC
    Pediatr Rheumatol Online J; 2023 May; 21(1):45. PubMed ID: 37138335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.